Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fishburg is a biotechnology company based in Shanghai that specializes in the development of cell-cultured seafood, with a particular focus on high-value species such as eel. The company leverages advanced tissue engineering, cell line development, and bioprocessing technologies to create authentic fish meat products without the environmental impact of traditional fishing. Fishburg's platform includes the optimization of serum-free culture media and the scaling of bioreactor production to achieve cost-effective manufacturing. By providing sustainable and mercury-free seafood alternatives, the company aims to address global food security and ocean conservation challenges. The firm has successfully established stable cell lines and is working toward pilot-scale production of its flagship cultured eel products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FishBurg.